Rehovot, Israel

Alexander Aizikovich

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 1.7

ph-index = 1


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alexander Aizikovich: Innovator in Cannabinoid Purification and Therapeutics

Introduction

Alexander Aizikovich is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of cannabinoid purification and therapeutic compounds. With a total of 2 patents, Aizikovich's work focuses on innovative processes that enhance the extraction and application of cannabinoids.

Latest Patents

Aizikovich's latest patents include a process for the purification of tetrahydrocannabinolic- and cannabidiolic acid from plant material extract. This invention relates to a highly economic method for purifying cannabinoid acids, specifically THCA or CBDA, from crude cannabis plant material or cell cultures. The process utilizes ion exchange resins, allowing for the decarboxylation of the purified cannabinoid acid to yield THC or CBD. Another significant patent involves sulfonamide derivatives with therapeutic indications. This invention provides sulfonamide compounds that have a wide range of beneficial therapeutic applications, particularly as analgesic and anti-inflammatory agents.

Career Highlights

Throughout his career, Aizikovich has worked with prominent companies such as Al&am Pharmachem Ltd. and Pharmos Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and cannabinoid research.

Collaborations

Aizikovich has collaborated with notable coworkers, including Avihai Yacovan and Iris Alroy. These partnerships have likely enhanced his research and development efforts in the field of cannabinoid therapeutics.

Conclusion

Alexander Aizikovich is a distinguished inventor whose work in cannabinoid purification and therapeutic compounds has made a significant impact. His innovative patents and collaborations reflect his commitment to advancing the field of cannabinoid research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…